FDA experts give a thumbs-up to Aerie Pharma’s glaucoma drug
Aerie Pharmaceuticals $AERI appears to be on a glide path to an FDA approval for its glaucoma drug Rhopressa.
An expert panel convened by the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
